Stefanie P. Ferreri , Lori T. Armistead , Ben Urick , Tamera D. Hughes , Anne-Therese Hunt , J. Marvin McBride , Joshua Niznik , Ellen Roberts , Kimberly A. Sanders , Jan Busby-Whitehead
{"title":"Building primary care providers' confidence in deprescribing opioids and benzodiazepines in older adults","authors":"Stefanie P. Ferreri , Lori T. Armistead , Ben Urick , Tamera D. Hughes , Anne-Therese Hunt , J. Marvin McBride , Joshua Niznik , Ellen Roberts , Kimberly A. Sanders , Jan Busby-Whitehead","doi":"10.1016/j.rcsop.2025.100627","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Opioids and benzodiazepines (BZDs) are among the most prescribed medications that contribute to falls in older adults; however, little guidance exists on their safe prescribing and deprescribing. Although some resources are available to assist providers with opioid and BZD deprescribing, many report lack of confidence as a barrier. The objective of this study was to assess PCPs' confidence in their ability to deprescribe opioids and BZDs before and after an intervention.</div></div><div><h3>Methods</h3><div>We modified a validated deprescribing self-efficacy survey to assess primary care provider (PCP) confidence in deprescribing opioids and BZDs in older adults before and after a consultant pharmacist educational intervention. The survey consisted of 35 questions divided into three sections: deprescribing opioids (10 questions), deprescribing BZDs (10 questions), and deprescribing under potentially impeding circumstances [UPIC] (15 questions). The survey was sent to 88 PCPs using a modified Dillman method. We evaluated providers' confidence on a 100-point scale pre- and post-intervention, comparing the difference-in- differences (DID) in scores between the intervention and control groups.</div></div><div><h3>Results</h3><div>A total of 41 PCPs (46.6 %) completed the survey both pre-and post-intervention. The intervention group (<em>n</em> = 21) showed an improvement in their knowledge and self-efficacy skills by an average of 19.7 out of 100 points, while the control group (<em>n</em> = 20) improved by an average of 5.2 points. The DID in self-efficacy improvement between the two groups was +14.5 points (<em>p</em> = 0.003) overall. For each of the opioid-, BZD-, and UPIC-specific scores, the intervention group had a statistically significant DID compared to the control group (+15.8, <em>p</em> = 0.004; +14.2, <em>p</em> = 0.017; +13.9, <em>p</em> = 0.016, respectively).</div></div><div><h3>Conclusion</h3><div>This consultant pharmacist educational intervention improved PCPs' confidence in deprescribing opioids and BZDs in older adults.</div></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"19 ","pages":"Article 100627"},"PeriodicalIF":1.8000,"publicationDate":"2025-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Exploratory research in clinical and social pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S266727662500068X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Opioids and benzodiazepines (BZDs) are among the most prescribed medications that contribute to falls in older adults; however, little guidance exists on their safe prescribing and deprescribing. Although some resources are available to assist providers with opioid and BZD deprescribing, many report lack of confidence as a barrier. The objective of this study was to assess PCPs' confidence in their ability to deprescribe opioids and BZDs before and after an intervention.
Methods
We modified a validated deprescribing self-efficacy survey to assess primary care provider (PCP) confidence in deprescribing opioids and BZDs in older adults before and after a consultant pharmacist educational intervention. The survey consisted of 35 questions divided into three sections: deprescribing opioids (10 questions), deprescribing BZDs (10 questions), and deprescribing under potentially impeding circumstances [UPIC] (15 questions). The survey was sent to 88 PCPs using a modified Dillman method. We evaluated providers' confidence on a 100-point scale pre- and post-intervention, comparing the difference-in- differences (DID) in scores between the intervention and control groups.
Results
A total of 41 PCPs (46.6 %) completed the survey both pre-and post-intervention. The intervention group (n = 21) showed an improvement in their knowledge and self-efficacy skills by an average of 19.7 out of 100 points, while the control group (n = 20) improved by an average of 5.2 points. The DID in self-efficacy improvement between the two groups was +14.5 points (p = 0.003) overall. For each of the opioid-, BZD-, and UPIC-specific scores, the intervention group had a statistically significant DID compared to the control group (+15.8, p = 0.004; +14.2, p = 0.017; +13.9, p = 0.016, respectively).
Conclusion
This consultant pharmacist educational intervention improved PCPs' confidence in deprescribing opioids and BZDs in older adults.